Sponsored Links 
Buy CHINA Up to $2.50 per Share
With a strong track record in consolidation and organic growth of its software business, we believe CDC Corporation (CHINA - Snapshot Report) is poised for growth.
The company's Q4 2008 results were hurt by impairment charges and a decline in software revenue. With continuous focus on vertical industries and cost reduction initiatives in its software segment, CDC should develop a significant competitive advantage in 2009 and beyond.
New launches and upgrades (Yulgang 3.0 and Ross Enterprise v6.3.2) in its product line as well as its integration efforts will further help the company drive growth. As such, we maintain our Buy rating on the shares of CDC with a six-month target price of $2.50.
Priyanka Poddar contributed to this report.
 |
 |
 Share |
 RSS |
 Rate Pos |
 Rate Neg |
 Comment |
|
|
||||||
Loading Stories...Related Content
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
- Free Four Zacks #1 Rank "Strong Buy" Stocks
- Free Timely Market Commentary
- Free Wealth Management Tips
- Free Profitable Strategy Screens
- Free Bull and Bear Stocks of the Day
Zacks FREE Registration
X Close
Loading Stories...Most Popular on Zacks.com
-3.14 %
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
More Zacks Links
| Market Summary | Nov 26, 2009 09:44 am ET |
30.69
Sponsored Links
[CLICK TO CLOSE X]